Skip to main content
. 2008 Jan 16;46(3):1116–1117. doi: 10.1128/JCM.01188-07

TABLE 2.

In vitro activities of fluoroquinolones against 187 Korean C. difficile isolates according to toxigenic status

Toxin status (no. of isolates tested) Antimicrobial agent MIC (μg/ml)
Range MIC50 MIC90
A+ B+ (115) Norfloxacin 16-256 64 128
Ciprofloxacin 4-128 16 32
Ofloxacin 8-256 64 128
Levofloxacin 2-128 32 64
Gatifloxacin 1-32 8 8
Moxifloxacin 1-16 8 8
A B+ (31) Norfloxacin 32-128 64 128
Ciprofloxacin 8-64 32 32
Ofloxacin 8-256 128 256
Levofloxacin 4-128 64 128
Gatifloxacin 1-32 32 32
Moxifloxacin 1-32 32 32
A B (41) Norfloxacin 32-128 32 64
Ciprofloxacin 4-32 8 8
Ofloxacin 8-256 8 8
Levofloxacin 4-128 4 4
Gatifloxacin 1-32 1 2
Moxifloxacin 1-16 1 2
HHS Vulnerability Disclosure